Morris JC - Search Results

1

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease.

Horie K, Salvadó G, Barthélemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O, Pichet Binette A, Palmqvist S, Sato C, Sachdev P, Koyama A, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Mattsson-Carlgren N, Stomrud E, Ossenkoppele R, Schindler SE, Hansson O, Bateman RJ. Horie K, et al. Among authors: morris jc. Nat Med. 2023 Aug;29(8):1954-1963. doi: 10.1038/s41591-023-02443-z. Epub 2023 Jul 13. Nat Med. 2023. PMID: 37443334 Free PMC article.

2

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM. Fagan AM, et al. Among authors: morris jc. Ann Neurol. 2006 Mar;59(3):512-9. doi: 10.1002/ana.20730. Ann Neurol. 2006. PMID: 16372280

3

The search for antecedent biomarkers of Alzheimer's disease.

Fagan AM, Csernansky CA, Morris JC, Holtzman DM. Fagan AM, et al. Among authors: morris jc. J Alzheimers Dis. 2005 Mar;8(4):347-58. doi: 10.3233/jad-2005-8404. J Alzheimers Dis. 2005. PMID: 16556966 Review.

4

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM. Bateman RJ, et al. Among authors: morris jc. Nat Med. 2006 Jul;12(7):856-61. doi: 10.1038/nm1438. Epub 2006 Jun 25. Nat Med. 2006. PMID: 16799555 Free PMC article.

5

Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.

Csernansky JG, Dong H, Fagan AM, Wang L, Xiong C, Holtzman DM, Morris JC. Csernansky JG, et al. Among authors: morris jc. Am J Psychiatry. 2006 Dec;163(12):2164-9. doi: 10.1176/ajp.2006.163.12.2164. Am J Psychiatry. 2006. PMID: 17151169 Free PMC article.

6

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Fagan AM, et al. Among authors: morris jc. Arch Neurol. 2007 Mar;64(3):343-9. doi: 10.1001/archneur.64.3.noc60123. Epub 2007 Jan 8. Arch Neurol. 2007. PMID: 17210801

7

Fluctuations of CSF amyloid-beta levels: implications for a diagnostic and therapeutic biomarker.

Bateman RJ, Wen G, Morris JC, Holtzman DM. Bateman RJ, et al. Among authors: morris jc. Neurology. 2007 Feb 27;68(9):666-9. doi: 10.1212/01.wnl.0000256043.50901.e3. Neurology. 2007. PMID: 17325273

8

Extreme cerebrospinal fluid amyloid beta levels identify family with late-onset Alzheimer's disease presenilin 1 mutation.

Kauwe JS, Jacquart S, Chakraverty S, Wang J, Mayo K, Fagan AM, Holtzman DM, Morris JC, Goate AM. Kauwe JS, et al. Among authors: morris jc. Ann Neurol. 2007 May;61(5):446-53. doi: 10.1002/ana.21099. Ann Neurol. 2007. PMID: 17366635

9

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.

Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: morris jc. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4. doi: 10.1073/pnas.0801227105. Epub 2008 Jun 9. Proc Natl Acad Sci U S A. 2008. PMID: 18541914 Free PMC article.

10

Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.

Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM. Kauwe JS, et al. Among authors: morris jc. Neurogenetics. 2009 Feb;10(1):13-7. doi: 10.1007/s10048-008-0150-4. Epub 2008 Sep 24. Neurogenetics. 2009. PMID: 18813964 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,650 results

Search Page